Clinical Trial Update: A Phase 2a Study of BIIB074 in the Treatment of Erythromelalgia [Phase 2]

View source ↗

Summary

Phase 2a study of BIIB074 in primary inherited erythromelalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inherited Erythromelalgia

Drugs mentioned

• BIIB074

Snippet

Sponsor: Biogen | Conditions: Primary Inherited Erythromelalgia | Phase 2 | Status: COMPLETED